Title : Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.

Pub. Date : 2008 Nov

PMID : 18780770






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance. ciglitazone peroxisome proliferator activated receptor gamma Mus musculus
2 Although PPARgamma agonists such as ciglitazone (CZ) are known to modulate diabetic nephropathy, the role of CZ in diabetes-associated HHcy and renopathy is incompletely defined. ciglitazone peroxisome proliferator activated receptor gamma Mus musculus
3 Although PPARgamma agonists such as ciglitazone (CZ) are known to modulate diabetic nephropathy, the role of CZ in diabetes-associated HHcy and renopathy is incompletely defined. ciglitazone peroxisome proliferator activated receptor gamma Mus musculus
4 We tested the hypothesis that induction of PPARgamma by CZ decreases tissue Hcy level; this provides a protective role against diabetic nephropathy. ciglitazone peroxisome proliferator activated receptor gamma Mus musculus
5 CZ, however, protected diabetic nephropathy in part by activating PPARgamma and clearing glomerular tissue Hcy. ciglitazone peroxisome proliferator activated receptor gamma Mus musculus